G/LIC/N/2/HKG/5  
 
27 January 2015  
(15-0558)  Page: 1/2  
Committee on Import Licensing  Original: English  
 
  AGREEMENT ON IMPORT LICENSING PROCEDURES 
NOTIFICATION UNDER ARTICLE 5  
HONG KONG, CHINA 
 
 The following communication, dated 22 January 2015, is being circulated at the request of the 
delegation of Hong Kong, China. 
 
_______________ 
 
Pursuant to Article 5 of the Agreement on Import Licensing Procedures, Hong Kong, China hereby 
notifies that the licensing control for the import  of proprietary Chinese medicines and 36 Chinese 
herbal medicines into the Hong Kong Special Ad ministrative Region has been updated with the 
following details at the (b) Contact point for information on eligibility. 
 (a) List of products subject to licensing procedures 
 
Any article specified in Sections 2A, 2B and 2C of Part I of the First Schedule of the Import 
and Export (General) Regulations, Cap. 60A, wh ich are listed below, are subject to import 
licensing procedures: 
 
- 31 Chinese herbal medicines specified in Schedule 1 of the Chinese Medicine 
Ordinance (Cap 549);  
 
- 5 Chinese herbal medicines specified in Schedule 2 of the Chinese Medicine Ordinance 
(Cap 549), namely, Flos Campsis, Processed Radix Aconiti, Processed Radix Aconiti 
Kusnezoffii, Radix Clematidis and Radix Gentianae; 
 
- Proprietary Chinese medicines as defined in Section 2 of the Chinese Medicine 
Ordinance (Cap 549). 
 
(b) Contact point for information on eligibility  
 
Chinese Medicines Section, Chinese Medicine Division, Department of Health, 16/F, AIA 
Kowloon Tower, Landmark East, 100 Ho w Ming Street, Kwun Tong, Kowloon, 
Hong Kong, China. 
 
(c) Administrative body for submission of applications 
 
See Item (b). 
 
(d) Date and name of publication where licensing procedures are published 
 
The Chinese Medicine Ordinance (Commencement) Notice 2007 was gazetted on 
16 November 2007.  It stipulates 11 January 2008 to be the date on which, among others, the relevant provisions of the Chinese Medicine Ordinance (Cap 549) including the 
consequential amendment to the Import and Ex port (General) Regulations, Cap. 60A shall 
come into operation. G/LIC/N/2/HKG/5 
 
- 2 - 
 
   
(e) Indication of whether the licensing procedure is automatic or non-automatic according to 
definitions contained in Articles 2 and 3 
 
The licensing procedure is non-automatic. 
 (f) In the case of automatic import licensi ng procedures, their administrative purpose 
 
 Not applicable.  (g) In the case of non-automatic import licensing procedures, indication of the measure being 
implemented through the licensing procedures 
 
The import licensing procedure aims to establish a mechanism to regulate, inter alia, the 
import of the proprietary Chinese medicines and 36 Chinese herbal medicines into Hong 
Kong Special Administrative Region.  The applicant is required to hold an appropriate trader’s licence issued by the Chinese Medicine Board prior to the application for an import 
licence.  Unless otherwise stated, an import licence is valid for six months.  
  (h) Expected duration of the licensing procedure if this can be estimated with some probability, 
and if not, reason why this information cannot be provided 
 
Two working days after submission of application for the import licence, subject to the availability of sufficient information. 
 
  
__________